Package 0597-0380-13

{"route": ["ORAL"], "spl_id": "ca86ce8b-9c04-47d8-94e3-ae041f251fab", "openfda": {"nui": ["N0000187059", "N0000187058", "N0000175912", "N0000175913"], "unii": ["HDC1R2M35U", "3X29ZEJ4R2", "786Z46389E"], "rxcui": ["2359279", "2359285", "2359288", "2359290", "2359351", "2359353", "2359356", "2359358"], "spl_set_id": ["71873567-9594-452a-bb92-34a129adecac"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0380-13)", "package_ndc": "0597-0380-13", "marketing_start_date": "20200423"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0380-68)", "package_ndc": "0597-0380-68", "marketing_start_date": "20200423"}], "brand_name": "Trijardy XR", "product_id": "0597-0380_ca86ce8b-9c04-47d8-94e3-ae041f251fab", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Biguanide [EPC]", "Biguanides [CS]", "Dipeptidyl Peptidase 4 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]", "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "0597-0380", "generic_name": "empagliflozin, linagliptin, metformin hydrochloride", "labeler_name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Trijardy XR", "active_ingredients": [{"name": "EMPAGLIFLOZIN", "strength": "10 mg/1"}, {"name": "LINAGLIPTIN", "strength": "5 mg/1"}, {"name": "METFORMIN HYDROCHLORIDE", "strength": "1000 mg/1"}], "application_number": "NDA212614", "marketing_category": "NDA", "marketing_start_date": "20200423", "listing_expiration_date": "20271231"}